The Washington Post reports that US Department of Agriculture researchers will no longer have to label their peer-reviewed articles as "preliminary."
In PNAS this week: analysis of Finland-United States Investigation of Non-Insulin-Dependent Diabetes Mellitus Genetics study samples, chromosome loss and gain in prostate cancer, and more.
Researchers uncovered deep-sea fish with additional rod pigment protein genes that may let them see color, according to the Los Angeles Times.
NPR reports on a clinical trial examining an antisense oligonucleotide drug for Huntington's disease.
CNN reports on Stanford University's Ron Davis' quest to study chronic fatigue syndrome.
In PLOS this week: profile of a yeast mycoparasite, biology of complex diseases, and more.
Demand for lab workers is growing, but so is the shortage of skilled technicians.
US lawmakers are proposing a bill that would reduce the use of non-human primates in biomedical research, Nature News reports.
The NIH says it should be able to hit 1 million volunteers for the All of Us research study within five to six years, reports ScienceInsider.
In Science this week: adenine base editors unexpectedly edit cellular RNA, and more.
A cystic fibrosis patient recovered from a serious post-surgical Mycobacterium abscessus infection with the help of a genetically-engineered phage cocktail treatment.
A Toronto company has developed a three-gene test aimed at identifying individuals at risk of adverse responses to cannabis.
New research, and a burgeoning company, point to the possible benefits of deep data profiling on healthy individuals, but critics aren't convinced.
In Nature this week: a next-generation characterization of the Cancer Cell Line Encyclopedia, and more.
A report from the National Academies says researchers, academic institutions, journals, and funders need to take steps to improve reproducibility and replicability in science.
US laws are falling behind the rapid progress of genetic testing technologies, and the lawsuits are starting to pile up, Science Magazine says.
The NIH has reached an agreement with the Navajo Nation to allow researchers to access health data from tribe members, Nature News reports.
In Nucleic Acids Research this week: a pipeline for developing multi-locus sequence analysis-based bacterial trees, a chromatin state sequence comparison tool, and more.
Business Insider reports that uBiome halted the sale and testing of its SmartJane and SmartGut tests.
At the BMJ, David Shaw from the University of Basel and Maastricht University critiques the National Health Service's clinical sequencing plan.
Reuters reports that on the launch of Verve Therapeutics, a biotech focused on using gene editing to treat cardiovascular disease.
In PNAS this week: sequencing of Globular Amphora culture individuals, characterization of effects of variants of unknown significance in EGFR, and more.
The Wall Street Journal reports that the US National Institutes of Health is to allow two clinicians critical of a clinical trial to speak with investigators.
Researchers tie genetic variants to traits linked to exercise-associated collapse among athletes with sickle cell trait, New Scientist reports.
Researchers question the value of a predictive genetic test for obesity, NPR reports.
Researchers who go persevere after an early funding setback end up with more highly cited papers later on, according to the Economist.
Nature News reports that female scientists setting up their first labs tend to have lower salaries and smaller staffs than their male peers.
A new analysis by Northwestern University researchers finds that female and male first-time PIs receive differing amounts of funding.
Some 43 percent of new mothers and 23 percent of new fathers leave full-time employment in STEM in the years after having a child, Science Careers says.